Brickell Biotech

Brickell Biotech Intangible Assets

Delisted

Intangible Assets of Brickell Biotech (BBI) as of Nov 4, 2026.

Intangible Assets

0.00USD

Last updated:

Intangible Assets of Brickell Biotech is 2019 0.00 USD. Intangible Assets of Brickell Biotech was 2018 0.00 USD. It decreases by % lower compared to the previous year.

The Brickell Biotech Intangible Assets history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

Intangible Assets
Date
Intangible Assets
Jan 1, 2014
1.70 M USD
Jan 1, 2015
1.30 M USD
Jan 1, 2016
810,000.00 USD
Jan 1, 2017
703,000.00 USD
Jan 1, 2018
0.00 USD
Jan 1, 2019
0.00 USD
The Brickell Biotech Intangible Assets history
YEARIntangible AssetsYoY
0.00USD—
0.00USD-100.00%
703,000.00USD-13.21%
810,000.00USD-37.69%
1.30 MUSD-23.53%
1.70 MUSD—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Brickell Biotech Stock analysis

What does Brickell Biotech do? Brickell Biotech Inc is a biopharmaceutical company that focuses on the development and marketing of innovative dermatology products. The company was founded in 2009 and is headquartered in Boulder, Colorado (USA), with branches in California and Singapore. The history of Brickell Biotech dates back to the 1960s when the company was originally founded under the name Brickell Research Inc. Over the following decades, the company specialized in biological research and conducted important research that forms the basis for today's product development. Brickell Biotech's business model is based on the creation of new and innovative therapies for the treatment of various dermatological diseases. In recent years, the company has entered into a number of important partnerships to accelerate its product development and strengthen its position in the industry. Brickell Biotech operates in two main areas: pharmaceuticals and cosmetic products. In the pharmaceuticals area, the company has a number of promising therapies in the pipeline that target the treatment of skin cancer, psoriasis, and other dermatological conditions. The company's flagship product is Sofpironium Bromide, a potential treatment for hyperhidrosis (excessive sweating). In the cosmetic products area, the company has developed a range of skincare products tailored to the needs of people with sensitive, dry, or aging skin. These products include moisturizers, cleansers, and anti-aging products, all made from high-quality ingredients. Brickell Biotech works closely with the scientific community to explore the latest developments and innovations in dermatology and the cosmetics industry. The company has also established a strong presence in the medical and research sectors by collaborating closely with leading universities and medical institutions worldwide. Overall, Brickell Biotech is a promising company in the biopharmaceutical and cosmetics industry, specializing in the development of new and innovative therapies for the treatment of skin conditions. With a strong pipeline of products and a dedicated leadership team, the company is expected to continue growing and establish itself as an important player in the industry. Brickell Biotech is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Brickell Biotech stock

On Eulerpool you can find the complete historical development of Intangible Assets Brickell Biotech since 2006 – with annual values, charts, and detailed analysis.

Intangible assets are non-physical assets such as patents, trademarks, copyrights, and software. They can be significant value drivers for technology and pharmaceutical companies.

Intangible Assets's USD is a key factor for investors. Changes in this metric can signal improving or deteriorating fundamentals, directly impacting the stock price. On Eulerpool, you can track Intangible Assets's Brickell Biotech historically and in real time.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Balance Sheet — Brickell Biotech

All Key Metrics — Brickell Biotech